Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1998;31:809-814

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Harwalkar, S.
Right arrow Articles by Douglas, J. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Harwalkar, S.
Right arrow Articles by Douglas, J. G.

(Hypertension. 1998;31:809-814.)
© 1998 American Heart Association, Inc.


Scientific Contributions

Role of Phospholipase A2 Isozymes in Agonist-Mediated Signaling in Proximal Tubular Epithelium

Subash Harwalkar; Chung-Ho Chang; Nickolai O. Dulin; ; Janice G. Douglas

From the Department of Medicine, Division of Hypertension, Case Western Reserve University School of Medicine and University Hospitals of Cleveland, Cleveland, Ohio.

Correspondence to Dr Subash Harwalkar, Division of Hypertension, 10900 Euclid Ave, W-161, Case Western Reserve University, School of Medicine, Cleveland, OH 44106.

Abstract—Angiotensin II in proximal tubule epithelium is known to stimulate the release of arachidonic acid after stimulation of phospholipase A2 (PLA2) independent of phospholipase C–mediated signaling. Furthermore, an angiotensin II type 2 receptor subtype has been linked to this signaling cascade. We investigated the regulation and differential stimulation of PLA2s by comparing the PLA2 activities associated with the membranes and cytosol of rabbit renal proximal tubular epithelial cells after stimulation with angiotensin II, epidermal growth factor, and bradykinin. Both fractions demonstrated PLA2 activity that was dithiothreitol insensitive, required micromolar concentrations of Ca2+ for optimal activity, and was inhibited in a dose-dependent manner by an antiserum to a cytosolic PLA2 with a molecular mass of 85 kD. However, membrane-associated PLA2 did not demonstrate significant substrate specificity, whereas 1-steroyl-2-[14C]arachidonylphosphatidyl choline was the preferred substrate for cPLA2. An antiserum generated against mastoparan, a known PLA2 activator, inhibited membrane- but not cytosol-associated PLA2 activity. Membrane fractions showed a broad pH range (7.5 to 8.5) for optimal PLA2 activity, whereas cytosol was maximum at pH 9.5. Angiotensin II stimulated membrane-associated PLA2 activity by 88%, whereas bradykinin and epidermal growth factor inhibited activity by 54% and 41%, respectively. The three agonists stimulated cPLA2. Moreover, angiotensin II–induced activation of membrane-associated PLA2 preceded the activation of cPLA2. These results demonstrate differential localization and regulation of proximal tubular epithelial PLA2 isozymes, which may determine the pattern of subsequent arachidonic acid metabolism by the cytochrome P450 system.


Key Words: phospholipase A2 • mastoparan • angiotensin II • mitogen-activated protein kinase • bradykinin • isozymes • endothelium




This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
Y. Li, H. Yamada, Y. Kita, M. Kunimi, S. Horita, M. Suzuki, Y. Endo, T. Shimizu, G. Seki, and T. Fujita
Roles of ERK and cPLA2 in the Angiotensin II-Mediated Biphasic Regulation of Na+-HCO3- Transport
J. Am. Soc. Nephrol., February 1, 2008; 19(2): 252 - 259.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
T. Osanai, K. Magota, M. Tanaka, M. Shimada, R. Murakami, S. Sasaki, H. Tomita, N. Maeda, and K. Okumura
Intracellular Signaling for Vasoconstrictor Coupling Factor 6: Novel Function of {beta}-Subunit of ATP Synthase as Receptor
Hypertension, November 1, 2005; 46(5): 1140 - 1146.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
B. T. Andresen, G. G. Romero, and E. K. Jackson
AT2 Receptors Attenuate AT1 Receptor-Induced Phospholipase D Activation in Vascular Smooth Muscle Cells
J. Pharmacol. Exp. Ther., April 1, 2004; 309(1): 425 - 431.
[Abstract] [Full Text]


Home page
J. Am. Soc. Nephrol.Home page
Y. Zheng, S. Horita, C. Hara, M. Kunimi, H. Yamada, T. Sugaya, A. Goto, T. Fujita, and G. Seki
Biphasic Regulation of Renal Proximal Bicarbonate Absorption by Luminal AT1A Receptor
J. Am. Soc. Nephrol., May 1, 2003; 14(5): 1116 - 1122.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
S. Fatima, F. A. Yaghini, A. Ahmed, Z. Khandekar, and K. U. Malik
CaM kinase II{alpha} mediates norepinephrine-induced translocation of cytosolic phospholipase A2 to the nuclear envelope
J. Cell Sci., January 15, 2003; 116(2): 353 - 365.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
P. Downey, A. Sapirstein, E. O'Leary, T.-X. Sun, D. Brown, and J. V. Bonventre
Renal concentrating defect in mice lacking group IV cytosolic phospholipase A2
Am J Physiol Renal Physiol, April 1, 2001; 280(4): F607 - F618.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
E. Feraille and A. Doucet
Sodium-Potassium-Adenosinetriphosphatase-Dependent Sodium Transport in the Kidney: Hormonal Control
Physiol Rev, January 1, 2001; 81(1): 345 - 418.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
K. D. Croft, J. C. McGiff, A. Sanchez-Mendoza, and M. A. Carroll
Angiotensin II releases 20-HETE from rat renal microvessels
Am J Physiol Renal Physiol, September 1, 2000; 279(3): F544 - F551.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Metzler, Y. Hu, G. Sturm, G. Wick, and Q. Xu
Induction of Mitogen-activated Protein Kinase Phosphatase-1 by Arachidonic Acid in Vascular Smooth Muscle Cells
J. Biol. Chem., December 11, 1998; 273(50): 33320 - 33326.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
N. O. Dulin, A. Sorokin, and J. G. Douglas
Arachidonate-Induced Tyrosine Phosphorylation of Epidermal Growth Factor Receptor and Shc-Grb2-Sos Association
Hypertension, December 1, 1998; 32(6): 1089 - 1093.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
N. O. Dulin, L. D. Alexander, S. Harwalkar, J. R. Falck, and J. G. Douglas
Phospholipase A2-mediated activation of mitogen-activated protein kinase by angiotensin II
PNAS, July 7, 1998; 95(14): 8098 - 8102.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
H. Jiao, X.-L. Cui, M. Torti, C.-H. Chang, L. D. Alexander, E. G. Lapetina, and J. G. Douglas
Arachidonic acid mediates angiotensin II effects on p21ras in renal proximal tubular cells via the tyrosine kinase-Shc-Grb2-Sos pathway
PNAS, June 23, 1998; 95(13): 7417 - 7421.
[Abstract] [Full Text] [PDF]